We are pleased to inform that one of our portfolio companies, Curiox Biosystems Co., Ltd (“Curiox”), has made its Initial Public Offering (“IPO”) debut on the Korea Securities Dealers Automated Quotations (KOSDAQ) in South Korea on 10 August 2023 with an offer of 1,400,000 shares of its common stock at a price of 13,000 won per share.
Curiox is a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis. The funds raised through this IPO will enable Curiox to further invest in research and expand its market presence. Curiox has appointed Kiwoom Securities Corp. as the lead underwriter for the offering.
ZIG Ventures Limited (“ZIG”) currently holds 979,440 shares in Curiox. Being a foreign substantial shareholder of Curiox, ZIG has been imposed with a 2-year moratorium preventing it from trading its shares on the market during this period. The price of the Curiox’s shares is subject to market forces from time to time and at the end of the moratorium period may differ from the present quotation.
Shareholders may keep themselves informed from time to time via the Company’s website.
The Company Secretary
By order of the Board
31 August 2023